Chunyan Gu, Haibo Cheng, Hongbao Yang, Yong Bian, Yaohui Wang, Yifen Zhang, Michael Pisano, Gang Hu, Ye Yang. MK2 is a therapeutic target for high-risk multiple myeloma. haematol [Internet]. 2021Jun.1 [cited 2024Apr.24];106(6):1774-7. Available from: https://haematologica.org/article/view/9550